BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8957246)

  • 21. Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats.
    Hyytiä P; Bäckström P; Liljequist S
    Eur J Pharmacol; 1999 Jul; 378(1):9-16. PubMed ID: 10478559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The discriminative stimulus properties of self-administered ethanol are mediated by GABA(A) and NMDA receptors in rats.
    Hodge CW; Cox AA; Bratt AM; Camarini R; Iller K; Kelley SP; Mehmert KK; Nannini MA; Olive MF
    Psychopharmacology (Berl); 2001 Feb; 154(1):13-22. PubMed ID: 11292001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the competitive NMDA receptor antagonist CGP 37849 on performance of reference and working memory tasks by rats.
    Deacon RM; Rawlins JN
    Eur J Pharmacol; 1995 Jul; 280(2):239-42. PubMed ID: 7589194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model.
    Papp M; Moryl E; Maccecchini ML
    Eur J Pharmacol; 1996 Dec; 317(2-3):191-6. PubMed ID: 8997600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competitive and non-competitive NMDA receptor antagonists induce c-Fos expression in the rat anterior, cingulate cortex.
    Wedzony K; Czyrak A
    J Physiol Pharmacol; 1996 Sep; 47(3):525-33. PubMed ID: 8877908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.
    Grant KA; Colombo G; Grant J; Rogawski MA
    Neuropharmacology; 1996; 35(12):1709-19. PubMed ID: 9076750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rewarding properties of non-competitive and competitive NMDA antagonists as measured by place preference conditioning in rats.
    Papp M; Moryl E
    Pol J Pharmacol; 1994; 46(1-2):79-81. PubMed ID: 7981776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats.
    Dall'olio R; Rimondini R; Gandolfi O
    Pharmacol Res; 1997 Sep; 36(3):203-9. PubMed ID: 9367665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-methyl-D-aspartate receptor antagonists are less effective in blocking long-term potentiation at apical than basal dendrites in hippocampal CA1 of awake rats.
    Leung LS; Shen B
    Hippocampus; 1999; 9(6):617-30. PubMed ID: 10641754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats.
    Löscher W; Annies R; Hönack D
    Eur J Pharmacol; 1993 Oct; 242(3):263-74. PubMed ID: 7904243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats.
    Bespalov AY; Balster RL; Beardsley PM
    J Pharmacol Exp Ther; 1999 Jul; 290(1):20-7. PubMed ID: 10381755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W; Czyrak A; Wedzony K
    Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substitution profiles of N-methyl-D-aspartate antagonists in ethanol-discriminating inbred mice.
    Shelton KL
    Alcohol; 2004; 34(2-3):165-75. PubMed ID: 15902910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures.
    Liljequist S
    Eur J Pharmacol; 1991 Jan; 192(1):197-8. PubMed ID: 1674917
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
    Wlaź P
    Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
    Bobelis DJ; Balster RL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats.
    Wlaź P; Ebert U; Löscher W
    Neuropharmacology; 1999 Feb; 38(2):243-51. PubMed ID: 10218865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
    D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
    Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative stimulus effects of ethanol with a conditioned taste aversion procedure: lack of acetaldehyde substitution.
    Quertemont E
    Behav Pharmacol; 2003 Jul; 14(4):343-50. PubMed ID: 12838040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.